Under the collection of prescription drugs into the retail market, "chicken ribs" drugstore will be really fragrant?

Pharmaceutical Network Market Analysis: For a long time, the hospital market has been the main market for prescription drugs.
But now, with the development of the collection policy, pharmaceutical companies will compete through the principle of low price for stock, the winning enterprises to obtain most of the country's major public hospital sales market, and the failed enterprises lost the opportunity to share.
background, in order to increase the share of variety sales, the out-of-hospital retail market has become a new position for these pharmaceutical companies to compete, which was once regarded as "chicken ribs" of the pharmacy market has also received some attention.
so, will the "chicken rib" pharmacy really smell? In fact, not only domestic pharmaceutical companies, some of the original research enterprises are also moving towards the retail market.
example, AstraZenein chose to target the retail market after the fat-lowering drug "Rhysumvastatin Calcium" failed to bid for a "4 plus 7" collection and expansion.
,000 yuan in the first quarter of this year, AstraZenewan's ryshuastatin reached 410 million yuan in the pharmacy market, up nearly 70 percent from the same period last year, according to CMH.
that the retail market is indeed a good way to regain its former market share.
as prescription drugs move into the retail market, prescription manufacturers and pharmacies are actively engaged in more and deeper cooperation, and factory resources will be tilted toward pharmacies.
some of the past retail pharmacies with zero or negative gross margin in the sale of varieties have a good opportunity to bring new traffic growth opportunities to retail pharmacies, helping to improve their profitability.
a few days ago, ordinary people, one heart, Yifeng pharmacy, including listed pharmacy chain enterprises have issued prescription drug business strategy, in which Yifeng Pharmacy said it will expand the prescription drug market from three directions.
One is to improve the company's operating capacity and professional services capacity to undertake prescription ex-export, the second is to cooperate in depth with pharmaceutical companies to undertake prescription ex-flow, and the third is to build their own Internet hospital platform, to fully undertake prescription sources and terminals.
The industry believes that in the short term pharmacies are indeed expected to enjoy the industry dividends brought about by the collection, but in the long run, under the normalization of collection, the concentration of the pharmaceutical retail industry will continue to improve, with upstream prescription drug companies to develop bargaining power of large chain pharmacies more viable, or usher in a good opportunity, and small and medium-sized pharmacies will continue to be eliminated.
, in fact, in the pharmaceutical retail industry environment, in addition to the impact of collection, retail pharmacies are facing the pressure of transformation and upgrading.
challenge is that practicing pharmacists are "standard" in retail pharmacies.
in accordance with the requirements of the state, when operating, retail pharmacies need to have practicing pharmacists on the job.
, retail pharmacies should be satisfied with the operation of a practicing pharmacist on the job, each needs to equip at least 2 practicing pharmacists.
with the implementation of the newly revised Drug Administration Law and the gradual implementation of the drug classification management system, practicing pharmacists will play an increasingly important role in the production, operation and use of drugs.
The reality, however, is that the provision of practicing pharmacists is clearly not keeping pace with the demand of pharmacies, and while remote pharmacists can alleviate the problem of practicing pharmacists not being on duty, they are not a substitute for practicing pharmacists on the job."
this also allows only a few pharmacies to have practicing pharmacists "sitting in the hall".
It is learned that in recent years, many pharmacy chains are in the layout of DTP pharmacies, this model mainly sells high-margin drugs, new special drugs, self-cost drugs, equipped with practicing pharmacists to provide professional guidance and services, is the advanced model of retail pharmacies.
in the industry's view, prescription drugs to the retail market is a last-minute, but whether the market can bring real increment, in fact, it will take time to prove.
, however, for pharmacies, the trend of industry concentration, large chain pharmacies than small and medium-sized pharmacies are undoubtedly more viable.
.